Usefulness of insulinlike growth factors and their binding proteins in the diagnosis of disease

Current Opinion in Endocrinology and Diabetes

Volumn 4, Issue 1, 1997, Pages 26-35

  Clemmons, David R ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0004143503     PISSN: 10683097     EISSN: None     Source Type: Journal    
DOI: 10.1097/00060793-199702000-00004     Document Type: Article

References (78)

1. Jones JI, Clemmons DR: Insulin like growth factor and their binding proteins: biologic actions. Endocrine Rev 1995, 16:3-34.
2. Baxter RC, Martin JL: Binding proteins for insulin-like growth factors: structure, regulation and function. Prog Growth Factor Res 1989, 1:49-68.
3. Rechter MM: Insulin like growth factor binding proteins. Vitam Horm 1993, 47:1-114.
4. Wood WI, Cachianes G, Henzel WJ, Winslow GA, Spencer SA, Hellmiss R, Martin JL, Baxter RC: Cloning and expression of the GH dependent insulin like growth factor binding protein. Mol Endocrinol 1988, 2:1176-1185.
5. Guler H-P, Zapf J, Schmid C, Froesch ER: Insulin-like growth factors I and II in healthy man: estimations of half-lives and production rates. Acta Endocrinol 1989, 121:753-758.
6. Suwannichkul A, Allander SV, Morris SL, Powell DR: Glucocorticoids and insulin regulate expression of the human gene for insulin-like growth factor binding protein-1 through proximal promoter elements. J Biol Chem 1996, 269:30835-30841.
7. Ooi GT, Tseng LY, Tran MQ, Rechler MM: Insulin rapidly decreases insulin-like growth factor-binding protein-1 gene transcription in streptozotocin-diabetic rats. Mol Endocrinol 1992, 6:2219-2228.
8. Blum WF, Brier BH: Radioimmunoassays for IGFs and IGFBPs. Growth Regul 1994, 4(suppl 11):11-19.
9. Clemmons DR, Smith-Banks A, Celniker AC, Underwood LE: Reversal of diet-induced catabolism by infusion of recombinant insulin-like growth factor-I (IGF-I) in humans. J Clin Endocrinol Metab 1992, 75:234-238.
10. Ranke MB, Blum WF, Bierich JR: Clinical relevance of serum measurements of insulin-like growth factors and somatomedin binding proteins. Acta Paediatr Scand Suppl 1988, 347:114-126.
11. Rosenfeld RG, Wilson DM, Lee PDK, Hintz RL: Insulin-like growth factors I and II in evaluation of fetal growth retardation. J Pediatr 1986, 109:428-433.
12. Donaldson DL, Pan F, Hollowell JC, Stevenson JL, Gifford RA, Moore WV: Reliability of stimulated and spontaneous growth hormone levels for Identifying the child with low growth hormone secretion. J Clin Endocrinol Metab 1991, 72:647-652.
13. Blum WF, Albertsson-Wikland K, Rosberg S, Ranke MB: Serum levels of insulin-like growth factor I (IGF-I) and IGF binding protein 3 reflect spontaneous growth hormone secretion. J Clin Endocrinol Metab 1993, 76:1610-1616.
14. Argenté J, Barrios V, Pozo J, Munoz MT, Hervas F, Stene M, Hernandez M: Normative data for insulin-like growth factors (IGFs), IGF binding proteins, and growth hormone-binding protein in a healthy Spanish pediatric population: age- and sex-related changes. J Clin Endocrinol Metab 1993, 77:1522-1528.
15. Nunez SB, Municchi G, Barnes KM, Rose SR: Insulin-like growth factor I (IGF-I) and IGF binding protein-3 concentrations compared to stimulated and night growth hormone in the evaluation of short children: a clinical research center study. J Clin Endocrinol Metab 1996, 81:1927-1932. This report presents well-defined criteria for using insulinlike growth factor-I and insulinlike growth factor binding protein-3 to screen for the presence of growth hormone deficiency in children.
16. Smith WJ, Underwood LE, Clemmons DR: Effects of caloric or protein restriction on insulin-like growth factor-I (IGF-I) and IGF-binding proteins in children and adults. J Clin Endocrinol Metab 1995, 80:443-449.
17. Juul A, Dalgaard P, Blum WF, Bang P, Hall K, Michaelsen KF, Muller J, Skakkebaek NE: Serum levels of insulin-like growth factor (IGF) binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation. J Clin Endocrinol Metab 1995, 80:2534-2542. This report emphasizes the strong link between insulinlike growth factor binding protein-3, insulinlike growth factor-I, and body mass index.
18. Spagnoli A, Gargosky SE, Spadoni GL, MacGillivray M, Oh Y, Boscherini B, Rosenfeld RG: Characteriation of a low molecular mass form of insulin-like growth factor binding protein-3 (17.7 kilodaltons) in urine and serum from healthy children and growth hormone (GH)-deficient patients: relationship with GH therapy. J Clin Endocrinol Metab 1995, 80:3668-3676.
19. Cianfarani S, Boemi S, Spagnoli A, Cappa M, Argiro G, Vaccaro F, Manca-Bitti ML, Boscherini B: Is IGF binding protein-3 assessment helpful for the diagnosis of GH deficiency? Clin Endocrinol (Oxf) 1995, 43:43-47.
20. Smith WJ, Nam TJ, Underwood LE, Busby WJ, Celniker A, Clemmons DR: Use of insulin-like growth factor binding protein 2 (IGFBP-2), IGFBP-3 and IGF-I for assessing growth hormone status in short children. J Clin Endocrinol Metab 1993, 77:1294-1299.
21. Blum WF, Ranke MB, Kietzmann K, Gauggel E, Zeisel HJ, Bierich JR: A specific radioimmunoassay for the growth hormone (GH)-dependent somatomedin binding protein: its use for diagnosis of GH deficiency. J Clin Endocrinol Metab 1990, 70:1292-1298.
22. Hasegawa Y, Hasegawa T, Aso T, Kotoh S, Tsuchiya Y, Nose O, Ohyama Y, Araki K, Tanaka T, Saisyo S: Comparison between insulin-like growth factor-I (IGF-I) and IGF binding protein-3 (IGFBP-3) measurement in the diagnosis of growth hormone deficiency. Endocrine J 1996, 40:185-190.
23. Mohnike K, Kluba U, Blum WF, Aumann V, Vorwerk P, Mittler U: Serum concentrations of insulin-like growth factors (IGF)-I and IGF-II and IGF binding proteins (IGFBP)-2 and IGFBP-3 in 49 children with ALL, NHL or solid tumors. Klin Padiatr 1995, 207:225-229.
24. Baum HBA, Biller BMK, Katznelson L, Oppenheim DS, Clemmons DR, Cannistraro KB, Schoenfeld DA, Best SA, Klibanski A: Assessment of growth hormone (GH) secretion in men with adult-onset GH deficiency compared with that in normal men: a clinical research center study. J Clin Endocrinol Metab 1996, 81:84-92.
25. Bates AS, Evans AJ, Jones P, Clayton RN: Assessment of GH status in adults with GH deficiency using serum growth hormone, serum insulin-like growth factor-I and urinary growth hormone excretion. Clin Endocrinol 1995, 42:425-430. This report is an excellent analysis of the utility of these tests for screening the presence of growth hormone deficiency in adults.
26. Ghigo E, Aimaretti G, Gianotti L, Bellone J, Arvat E, Camanni F: New approach to the diagnosis of growth hormone deficiency in adults. Eur J Endocrinol 1996, 134:352-356.
27. Mandel S, Moreland E, Nichols V, Hanna C, LaFranchi S: Changes in insulin-like growth factor-I (IGF-I), IGF-binding protein-3, growth hormone GH-binding protein, erythrocyte IGF-I receptors, and growth rate during GH treatment. J Clin Endocrinol Metab 1995, 80:190-194.
28. Grinspoon S, Clemmons DR, Swearingen B, Klibanski A: Serum insulin-like growth factor-binding protein-3 levels in the diagnosis of acromegaly. J Clin Endocrinol Metab 1995, 80:927-932.
29. Clemmons DR, Underwood LE, Ridgway EG: Evaluation of acromegaly by radioimmunoassay of somatomedin-C. N Engl J Med 1979, 301:1138-1142.
30. Melmed S: Acromegaly. N Engl J Med 1990, 322:966-977.
31. Wass JAH, Clemmons DR, Underwood LE: Changes in circulating somatomedin-C levels in bromocriptine treated acromegaly. Clin Endocrinol 1982, 17:369-377.
32. Juul A, Main K, Blum WF, Lindholm J, Ranke MB, Skakkebaek NE: The ratio between serum levels of insulin-like growth factor-I (IGF-I) and the IGF binding proteins (IGFBP-1, 2 and 3) decreases with age in healthy adults and is increased in acromegalic patients. Clin Endocrinol 1994, 41:85-93.
33. Busby WH, Snyder DK, Clemmons DR: Radioimmunoassay of a 26,000 dalton plasma insulin like growth factor binding protein: control by nutritional variables. J Clin Endocrinol Metab 1988, 67:1225-1230.
34. Suikkari A, Koivisto V, Rutanen E, Yki-Jarvinen H, Karonen S, Seppala M: Insulin regulates the serum levels of low molecular weight insulin-like growth factor binding protein. J Clin Endocrinol Metab 1988, 66:266-272.
35. Bereket A, Lang CH, Blethen SL, Gelato MC, Fan J, Frost RA, Wilson TA: Effect of insulin on the insulin-like growth factor system in children with new onset insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1995, 80:1312-1317.
36. Rajkumar K, Krsek M, Dheen ST, Murphy LJ: Impaired glucose homeostasis in insulin-like growth factor binding protein-1 transgenic mice. J Clin Invest 1996, 98:1818-1825.
37. Jorgenson JO, Pederson SB, Borglum J, Frystyk J, Ho KK, Christiansen JS, Orskov H, Blum WF, Richelsen B: Serum concentrations of insulin-like growth factors (IGFs), IGF binding proteins 1 and 3 and growth hormone binding protein in obese women and the effects of growth hormone administration: a double-blind, placebo-controlled study. Eur J Endocrinol 1995, 133:65-70.
38. Ismail IS, Miell JP, Scanion MF, Peters JR: Effects of cholinergic modulation on serum insulin-like growth factor-I and its binding proteins in normal and diabetic subjects. Clin Endocrinol 1995, 42:147-152.
39. Tapanainen P, Kaar ML, Leppaluoto J, Huttunen NP, Knip M: Normal stimulated growth hormone secretion but low peripheral levels of insulin-like growth factor I in prepubertal children with insulin-dependent diabetes mellitus. Acta Paediatr 1995, 84:6546-6650.
40. Hilding A, Brismar K, Degerglad M, Thoren M, Hall K: Altered relation between circulating levels of insulin-like growth factor binding protein-1 and insulin in growth hormone deficient patients and insulin-dependent diabetic patients compared to that in healthy subjects. J Clin Endocrinol Metab 1995, 80:2646-2652.
41. Bereket A, Lang CH, Blethen SL, Wilson TA: Insulin-like growth factor binding protein-2 and insulin: studies in children with type I diabetes mellitus and maturity-onset diabetes of the young. J Clin Endocrinol Metab 1995, 80:3647-3652.
42. Yki-Jarvinen H, Makimattila S, Utriainen T, Rutanen E: Portal insulin concentrations rather than insulin sensitivity regulate serum sex hormone binding globulin and insulin-like growth factor binding protein 1 in vivo. J Clin Endocrinol Metab 1995, 80:3227-3232.
43. Simmons D: Interrelation between umbilical cord serum sex hormones, sex hormone-binding globulin, insulin-like growth factor I, and insulin in neonates from normal pregnancies and pregnancies complicated by diabetes. J Clin Endocrinol Metab 1995, 80:2217-2221.
44. Bereket A, Lang CH, Blethen SL, Fan J, Frost RA, Wilson TA: Insulin-like growth factor binding protein-3 proteolysis in children with insulin-dependent diabetes mellitus: a possible role for insulin in the regulation of IGFBP-3 protease activity. J Clin Endocrinol Metab 1995, 80:2282-2288.
45. Westwood M, Gibson JM, Williams AC, Clayton PE, Hamberg O, Flyvbjerg A, White A: Hormonal regulation of circulating insulin-like growth factor binding protein-1 phosphorylation status. J Clin Endocrinol Metab 1995, 80:3520-3527.
46. Ebeling P, Stenman UH, Seppala M, Koivisto VA: Acute hyperinsulinemia, androgen homeostasis and insulin sensitivity in healthy men. J Endocrinol 1995, 146:63-69.
47. Gibson JM, Westwood M, Crosby SR, Gordon C, Holly JMP, Fraser W, Anderson C, White A, Young RJ: Choice of treatment affects plasma levels of insulin-like growth factor binding protein-1 in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1995, 80:1369-1375.
48. Dills DG, Allen C, Palta M, Zaccaro DJ, Klein R, D'Alessio D: Insulin-like growth factor-I is related to glycemic control in children and adolescents with newly diagnosed insulin-dependent diabetes. J Clin Endocrinol Metab 1995, 80:2139-2143.
49. Stroesser-Vogel B, Blum WF, Past R, Kessler U, Hoeflich A, Meiler B, Kiess W: Insulin-like growth factor (IGF)-I and -II and IGF binding proteins-1, 2, and -3 in children and adolescents with diabetes mellitus: correlation with metabolic control and height adjustment. J Clin Endocrinol Metab 1995, 80:1207-1213.
50. Cotterill AM, Daly F, Holly JM, Hughes SC, Camacho-Hubner C, Abdulla AF, Gale EA, Savage MO: The 'dawn phenomenon' in adolescents with insulin dependent diabetes mellitus: possible contribution of insulin-like growth factor binding protein-1. Clin Endocrinol 1995, 43:567-574.
51. Knip M, Tapanainen P, Pekonen F, Blum WF: Insulin-like growth factor binding proteins in prepubertal children with insulin-dependent diabetes mellitus. J Endocrinol 1995, 133:440-444.
52. Grant MB, Schmetz I, Russell B, Harwood HJ, Silverstein J, Merimee TJ: Changes in insulin-like growth factors I and II and their binding protein after a single intramuscular injection of growth hormone. J Clin Endocrinol Metab 1986, 63:981-984.
53. Meyer-Schwickerath R, Pfeiffer A, Blum WF, Freyberger H, Klein M, Losche C, Rollmann R, Schatz H: Vitreous levels of the insulin-like growth factors I and II, and the insulin-like growth factor binding proteins 2 and 3, increase in neovascular eye disease. J Clin Invest 1993, 92:2620-2625.
54. Wang Q, Dills DG, Klein R, Klein BE, Moss SE: Does insulin-like growth factor I predict incidence and progression of diabetic retinopathy? Diabetes 1995, 44:161-164.
55. Gibson JM, Westwood M, Young RJ, White A: Reduced insulin-like growth factor binding protein-I (IGFBP-1) levels correlate with increased cardiovascular risk in non-insulin dependent diabetes mellitus (NIDDM). J Clin Endocrinol Metab 1996, 81:860-863.
56. Rudberg S, Persson B: Association between lipoprotein (a) and insulin-like growth factor I during puberty and the relationship to microalbuminuria in children and adolescents with IDDM. Diabetes Care 1996, 18:933-939.
57. Olivecrona H, Johansson AG, Lindh E, Ljunghall S, Berglund L, Angelin B: Hormonal regulation of serum lipoprotein(a) levels: contrasting effects of growth hormone and insulin-like growth factor-1. Arterioscler Thromb Vasc Biol 1995, 15:847-849.
58. Migdalis IN, Kalogeropoulou K, Kalantzis L, Nounopoulos C, Bouloukos A, Samartzis M: Insulin-like growth factor-I and IGF-I receptors in diabetic patients with neuropathy. Diabetic Med 1995, 12:823-827.
59. Daughaday WH, Trivedi B, Baxter RC: Serum "big" insulin-like growth factor-II from patients with tumor hypoglycemia lacks normal E-domain O-linked glycosylation, a possible determinant of normal propeptide processing. Proc Natl Acad Sci USA 1993, 90:5283-5827.
60. Baxter RC, Holman SR, Corbould A, Stranks S, Ho PJ, Braund W: Regulation of the insulin-like growth factors and their binding proteins by glucocorticoid and growth hormone in nonislet cell tumor hypoglycemia. J Clin Endocrinol Metab 1995, 80:2700-2708.
61. Cohen P, Peehl DM, Staney TA, Wilson KF, Clemmons DR, Rosenfeld RE: Elevated levels of insulin like growth factor binding protein-2 in prostate cancer patients. J Clin Endocrinol Metab 1993, 76:1031-1035.
62. Tennant MK, Thrasher JB, Twomey PA, Birnbaum RS, Plymate SR: Insulin-like growth factor binding protein-2 and -3 expression in benign human prostate epithelium, prostate intraepithelial neoplasia, and adenocarcinoma. J Clin Endocrinol Metab 1996, 81:411-420.
63. Bruning PF, Van Doom J, Bonfrer JM, Van Noord PA, Korse CM, Linders TC, Hart AA: Insulin-like growth factor binding protein 3 is decreased in early stage operable pre-menopausal breast cancer. Int J Cancer 1995, 62:266-270.
64. Honda Y, Landale EC, Strong DD, Baylink DJ, Mohan S: Recombinant synthesis of insulin-like growth factor binding protein-4 (IGFBP-4): development, validation and appreciation of a radioimmunoassay for IGFBP-4 in human serum and other biological fluids. J Clin Endocrinol Metab 1996, 81:1389-1396.
65. Johansson AG, Forslund A, Hambraeus L, Blum WF, Ljunghall S: Growth hormone-dependent insulin-like growth factor binding protein is a major determinant of bone mineral density in healthy men. J Bone Miner Res 1994, 9:915-921.
66. Johansson AG, Baylink DJ, af Ekenstam E, Lindh E, Mohan S, Ljunghall S: Circulating levels of insulin-like growth factor-I and -II, and IGF-binding protein-3 in inflammation and after parathyroid hormone infusion. Bone Miner 1994, 24:25-31.
67. Juul A, Scheike T, Nielsen CT, Krabbe S, Muller J, Skakkebaek NE: Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 levels are Increased in central precocious puberty: effects of two different treatment regimens with gonadotropin releasing hormone agonists, without or in combination with an antiandrogen (cytoproterone acetate). J Clin Endocrinol Metab 1995, 80:3059-3067.
68. Pfeilschifter J, Scheidt-Nave C, Leidig-Bruckner G, Woitge HW, Blum WF, Wuster C, Haack D, Ziegler R: Relationship between circulating insulin-like growth factor components and sex hormones in a population based sample of 50- to 80-year-old men and women. J Clin Endocrinol Metab 1996, 81:2534-2540.
69. Langford KS, Nicolaides KH, Jones J, Abbas A, McGrefor AM, Miell JP: Serum insulin-like growth factor-binding protein-3 (IGFBP-3) levels and IGFBP-3 protease activity in normal, abnormal, and multiple human pregnancy. J Clin Endocrinol Metab 1995, 80:21-27.
70. Hasegawa T, Hasegawa Y, Takada M, Tsuchiya Y: The free form of insulin-like growth factor-I increases in circulation during normal human pregnancy. J Clin Endocrinol Metab 1995, 80:3284-3286.
71. Van Dessel HJHMT, Chandrasekher Y, Yap OWS, Lee PDK, Hintz RL, Faessen GHJ, Braat DDM, Fauser BCJM, Giudice LC: Serum and folllcular fluid levels of insulin-like growth factor-I (IGF-I), IGF-II, and IGF-binding protein-1 and -3 during the normal menstrual cycle. J Clin Endocrinol Metab 1996, 81:1224-1231.
72. Lang CH, Fan J, Frost RA, Gelato MC, Sakurai Y, Herndon DN, Wolfe RR: Regulation of the insulin-like growth factor system by insulin in burn patients. J Clin Endocrinol Metab 1996, 81:2474-2480.
73. Frost RA, Nachman SA, Lang CH, Gelato MC: Proteolysis of insulin-like growth factor-binding protein-3 in human immunodeficiency virus-positive children who fail to thrive. J Clin Endocrinol Metab 1996, 81:2957-2962.
74. Kratzsch J, Slum WF, Schenker E, Keller E: Regulation of growth hormone (GH), insulin-like growth factor (IGF) I, IGF binding proteins -1, -2, -3 and GH binding protein during progression of liver cirrhosis. Exp Clin Endocrinol Diabetes 1995, 103:285-291.
75. Crawford RA, Hills FA, Farkas A, Chard T: Elevated levels of insulin-like growth factor binding protein-1 in fetal distress. Br J Obstet Gynaecol 1995, 102:538-540.
76. Matsumolo T, Gargosky SE, Iwasaki K, Rosenfeld RG: Identification and characterization of insulin-like growth factors (IGFs), IGF-binding proteins (IGFBPs), and IGFBP proteases in human synovial fluid. J Clin Endocrinol Metab 1996, 81:150-155.
77. Olney RC, Tsuchiya K, Wilson DM, Mothai M, Maloney WJ, Schurman DJ, Smith RL: Chondrocytes from osteoarthritic cartilage have increased expression of insulin-like growth factor I (IGF-I) and IGF-binding protein-3 (IGFBP-3) and -5, but not IGF-II or IGFBP-4. J Clin Endocrinol Metab 1996, 81:1096-1103.
78. Tonshoff B, Blum WF, Wingen A, Mehls O: Serum insulin-like growth factors (IGFs) and IGF binding proteins 1, 2, and 3 in children with chronic renal failure: relationship to height and glomerular filtration rate. J Clin Endocrinol Metab 1995, 80:2684-2691.